Centiva Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,023
Closed -$615K 1468
2025
Q2
$615K Buy
+4,023
New +$618K 0.01% 862
2025
Q1
Sell
-6,867
Closed -$993K 1837
2024
Q4
$993K Sell
6,867
-1,604
-19% -$249K 0.02% 529
2024
Q3
$1.37M Buy
8,471
+4,070
+92% +$648K 0.03% 658
2024
Q2
$643K Buy
4,401
+4,371
+14,570% +$650K 0.01% 1003
2024
Q1
$4.75K Sell
30
-6,465
-100% -$1.03M ﹤0.01% 1697
2023
Q4
$1.02M Buy
6,495
+6,391
+6,145% +$980K 0.02% 613
2023
Q3
$16.2K Sell
104
-20,191
-99% -$3.33M ﹤0.01% 1645
2023
Q2
$3.36M Buy
20,295
+16,017
+374% +$2.59M 0.07% 265
2023
Q1
$663K Buy
4,278
+546
+15% +$88.2K 0.02% 737
2022
Q4
$659K Sell
3,732
-17,974
-83% -$3.1M 0.02% 686
2022
Q3
$3.53M Buy
21,706
+19,151
+750% +$3.24M 0.07% 218
2022
Q2
$436K Buy
2,555
+2,455
+2,455% +$437K 0.01% 973
2022
Q1
$0 Sell
100
-6,364
-98% -$1.08M ﹤0.01% 1717
2021
Q4
$1.11M Buy
6,464
+1,465
+29% +$240K 0.02% 579
2021
Q3
$791K Buy
4,999
+548
+12% +$93.5K 0.05% 414
2021
Q2
$733K Buy
4,451
+2,952
+197% +$489K 0.02% 688
2021
Q1
$246K Sell
1,499
-7,040
-82% -$1.14M 0.01% 891
2020
Q4
$1.34M Buy
+8,539
New +$1.26M 0.05% 215
2020
Q3
Sell
-81,510
Closed -$11.5M 785
2020
Q2
$11.5M Buy
81,510
+1,369
+2% +$200K 0.69% 16
2020
Q1
$10.5M Buy
80,141
+60,594
+310% +$8.6M 0.47% 23
2019
Q4
$2.85M Buy
19,547
+15,001
+330% +$2.03M 0.14% 142
2019
Q3
$589K Buy
+4,546
New +$599K 0.04% 286
2018
Q3
Sell
-80,000
Closed -$9.71M 196
2018
Q2
$9.71M Buy
+80,000
New +$9.98M 2.06% 7

Other funds holding JNJ

Centiva Capital's JNJ Position: Q3 2025 in Review

Centiva Capital sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 4,023 shares — an estimated $615K sold.

Centiva Capital first reported a position in JNJ in Q2 2018 and held it in 23 quarters. The position peaked at $11.5M in Q2 2020. 4,195 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Centiva Capital reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 4,023 Johnson & Johnson shares in Q3 2025, an estimated $615K.
  • Centiva Capital first reported a position in Johnson & Johnson in Q2 2018 and held it in 23 quarters.
  • Centiva Capital's Johnson & Johnson position peaked at $11.5M in Q2 2020.
  • 4,195 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.